Gilead Sciences Says Kite's Tecartus Granted Conditional Marketing Authorization For Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma In Europe
Gilead Sciences Inc :Kite’S Tecartus™ (Kte-X19) Granted Conditional Marketing Authorization For The